U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361653) titled 'The REVIVE Pivotal Study' on Jan. 21.
Brief Summary: The goal of this study is to test whether a new treatment called the Ryme Medical Targeted Lung Denervation (TLD) Catheter is safe and effective for people with moderate to severe chronic obstructive pulmonary disease (COPD).
The main questions it aims to answer are:
1. Does the TLD Catheter improve symptoms in people with COPD?
2. Is the TLD Catheter safe ?
Researchers will compare the group receiving the TLD treatment to the group receiving a sham procedure to see if the treatment improves quality of life.
Participants will:
1. Be randomly assigned to receive either the TL...